EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

New Trends of Personalized Medicine in the Management of Abdominal Aortic Aneurysm: A Review

Yaman Alsabbagh iD, Young Erben, Jonathan Vandenberg, Houssam Farres iD

Journal of Personalized Medicine · 10.12.2024 · 14 (12) · 1148

DOI: 10.3390/jpm14121148 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Personalized Medicine, online erschienen am 10.12.2024. Verfasst von Yaman Alsabbagh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Vascular and Endovascular Surgery, Mayo Clinic, Jacksonville, FL 32224, USA. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Abdominal aortic aneurysm (AAA) is a significant vascular condition characterized by the dilation of the abdominal aorta, presenting a substantial risk of rupture and associated high mortality rates. Current management strategies primarily rely on aneurysm diameter and growth rates to predict rupture risk and determine the timing of surgical intervention. However, this approach has limitations, as ruptures can occur in smaller AAAs below surgical thresholds, and many large AAAs remain stable without intervention. This review highlights the need for more precise and individualized assessment tools that integrate biomechanical parameters such as wall stress, wall strength, and hemodynamic factors. Advancements in imaging modalities like ultrasound elastography, computed tomography (CT) angiography, and magnetic resonance imaging (MRI), combined with artificial intelligence, offer enhanced capabilities to assess biomechanical indices and predict rupture risk more accurately. Incorporating these technologies can lead to personalized medicine approaches, improving decision-making regarding the timing of interventions. Additionally, emerging treatments focusing on targeted delivery of therapeutics to weakened areas of the aortic wall, such as nanoparticle-based drug delivery, stem cell therapy, and gene editing techniques like CRISPR-Cas9, show promise in strengthening the aortic wall and halting aneurysm progression. By validating advanced screening modalities and developing targeted treatments, the future management of AAA aims to reduce unnecessary surgeries, prevent ruptures, and significantly improve patient outcomes.

Schlagwörter

Stichwörter der Autor:innen

artificial intelligencebiomechanicscalcium scoreendovasculargenomicsstem cell

Autor:innen und Institutionen

  • Division of Vascular and Endovascular Surgery, Mayo Clinic, Jacksonville, FL 32224, USA.

ORCID-Profile: Yaman Alsabbagh, Houssam Farres

Zitieren

APA

Alsabbagh, Y., Erben, Y., Vandenberg, J., & Farres, H. (2024). New Trends of Personalized Medicine in the Management of Abdominal Aortic Aneurysm: A Review. Journal of Personalized Medicine, 14(12), 1148. https://doi.org/10.3390/jpm14121148

Vancouver

Alsabbagh Y, Erben Y, Vandenberg J, Farres H. New Trends of Personalized Medicine in the Management of Abdominal Aortic Aneurysm: A Review. Journal of Personalized Medicine. 2024;14(12):1148. doi:10.3390/jpm14121148

BibTeX
@article{Alsabbagh2024,
  author = {Alsabbagh, Yaman and Erben, Young and Vandenberg, Jonathan and Farres, Houssam},
  title = {New Trends of Personalized Medicine in the Management of Abdominal Aortic Aneurysm: A Review},
  journal = {Journal of Personalized Medicine},
  year = {2024},
  volume = {14},
  number = {12},
  pages = {1148},
  doi = {10.3390/jpm14121148}
}
Kostenlos starten →